Skip to main content
. 2017 Dec 5;9(2):2838–2847. doi: 10.18632/oncotarget.22974

Table 1. Patient characteristics and data on immunotherapy performed.

Patient Characteristics Immunotherapy Performed Crinical Response
Patient Age/Sex Location No. Courses No. DCs Administered (×106 cells) (Mean) No. abT cells Administered (×106 cells) (Mean) Progression Free survival (months) Overall Survival (months) Clinical Response (After 12th Infusion)
1 64/F body 11 3.1 7.0 4.5 11.5 PD
2 69/M head 8 7.7 5.7 3.6 17.7 PD
3 49/M body 12 11.0 6.2 6.3 10.0 SD*
4 69/F body 12 19.3 5.7 58.5 73.4 SD*
5 67/M body 1 18.4 6.8 5.7 7.6 PD
6 62/M body 5 14.4 6.7 2.5 6.4 PD
7 67/M body 12 16.2 6.2 17.7 37.7 SD*
8 75/M body 12 17.7 6.2 11.5 12.4 SD*
9 63/M body 12 25.0 4.2 12.9 38.6 SD*
10 66/F tail 10 39.0 5.3 3.6 5.0 PD
11 66/M head 5 34.0 5.4 1.7 15.0 PD
12 55/F head 12 20.3 7.2 21.3 26.8 SD*
13 58/F body 9 17.9 4.8 2.7 7.5 PD
14 54/M body 12 18.2 6.0 5.5 8.6 PD
15 71/M body 5 23.0 5.0 2.1 2.1 SD

* longer than 6 months SD